PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2090.0
(-1.42%)
IDR 2090.0
(-1.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1728.28 Billion IDR | 70.69% |
| 2022 | 1022.33 Billion IDR | 0.36% |
| 2021 | 1018.7 Billion IDR | 160.81% |
| 2020 | 390.59 Billion IDR | 915.16% |
| 2019 | 38.47 Billion IDR | -79.92% |
| 2018 | 191.65 Billion IDR | -12.6% |
| 2017 | 219.28 Billion IDR | -1.09% |
| 2016 | 221.69 Billion IDR | 40.26% |
| 2015 | 158.06 Billion IDR | 18.09% |
| 2014 | 133.85 Billion IDR | 70.11% |
| 2013 | 78.68 Billion IDR | -13.98% |
| 2012 | 91.46 Billion IDR | 28.52% |
| 2011 | 71.16 Billion IDR | -31.51% |
| 2010 | 103.9 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 456.1 Billion IDR | 3.15% |
| 2024 Q2 | 442.17 Billion IDR | -4.9% |
| 2024 Q1 | 464.96 Billion IDR | 1.41% |
| 2023 Q3 | 505.97 Billion IDR | 36.38% |
| 2023 Q2 | 371 Billion IDR | 1.03% |
| 2023 Q1 | 367.2 Billion IDR | 2.54% |
| 2023 FY | 1745.04 Billion IDR | 70.69% |
| 2023 Q4 | 458.5 Billion IDR | -9.38% |
| 2022 FY | 1022.33 Billion IDR | 0.36% |
| 2022 Q4 | 358.11 Billion IDR | 5.63% |
| 2022 Q3 | 339.01 Billion IDR | 106.12% |
| 2022 Q2 | 164.47 Billion IDR | 2.33% |
| 2022 Q1 | 160.72 Billion IDR | -13.08% |
| 2021 Q4 | 184.91 Billion IDR | -45.61% |
| 2021 Q2 | 240.18 Billion IDR | -5.3% |
| 2021 Q3 | 339.97 Billion IDR | 41.55% |
| 2021 FY | 1018.7 Billion IDR | 160.81% |
| 2021 Q1 | 253.63 Billion IDR | 16.26% |
| 2020 FY | 390.59 Billion IDR | 915.16% |
| 2020 Q2 | -107.42 Billion IDR | -195.61% |
| 2020 Q1 | 112.36 Billion IDR | 134.8% |
| 2020 Q4 | 218.16 Billion IDR | 30.26% |
| 2020 Q3 | 167.48 Billion IDR | 255.91% |
| 2019 FY | 38.47 Billion IDR | -79.92% |
| 2019 Q3 | 113.46 Billion IDR | 149.23% |
| 2019 Q2 | 45.52 Billion IDR | -28.45% |
| 2019 Q4 | -322.88 Billion IDR | -384.58% |
| 2019 Q1 | 63.62 Billion IDR | -10.0% |
| 2018 Q3 | 76.19 Billion IDR | 1018.88% |
| 2018 Q4 | 70.69 Billion IDR | -7.22% |
| 2018 FY | 191.65 Billion IDR | -12.6% |
| 2018 Q1 | 37.95 Billion IDR | -45.19% |
| 2018 Q2 | 6.81 Billion IDR | -82.06% |
| 2017 FY | 219.28 Billion IDR | -1.09% |
| 2017 Q3 | 76.85 Billion IDR | 1989.67% |
| 2017 Q1 | 69.51 Billion IDR | 128.16% |
| 2017 Q4 | 69.24 Billion IDR | -9.89% |
| 2017 Q2 | 3.67 Billion IDR | -94.71% |
| 2016 Q3 | 48 Billion IDR | -30.76% |
| 2016 FY | 221.69 Billion IDR | 40.26% |
| 2016 Q2 | 69.33 Billion IDR | -6.16% |
| 2016 Q1 | 73.88 Billion IDR | 331.02% |
| 2016 Q4 | 30.46 Billion IDR | -36.54% |
| 2015 Q1 | 64.06 Billion IDR | 92.84% |
| 2015 Q2 | 56.32 Billion IDR | -12.08% |
| 2015 FY | 158.06 Billion IDR | 18.09% |
| 2015 Q4 | 17.14 Billion IDR | -16.5% |
| 2015 Q3 | 20.52 Billion IDR | -63.55% |
| 2014 Q3 | 25.59 Billion IDR | -28.77% |
| 2014 Q2 | 35.93 Billion IDR | -8.12% |
| 2014 Q1 | 39.1 Billion IDR | -2.69% |
| 2014 FY | 133.85 Billion IDR | 70.11% |
| 2014 Q4 | 33.22 Billion IDR | 29.81% |
| 2013 Q4 | 40.18 Billion IDR | 707.2% |
| 2013 Q1 | 37.26 Billion IDR | 177.59% |
| 2013 FY | 78.68 Billion IDR | -13.98% |
| 2013 Q2 | -3.74 Billion IDR | -110.06% |
| 2013 Q3 | 4.97 Billion IDR | 232.78% |
| 2012 Q4 | 13.42 Billion IDR | 0.0% |
| 2012 FY | 91.46 Billion IDR | 28.52% |
| 2011 FY | 71.16 Billion IDR | -31.51% |
| 2010 FY | 103.9 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 211.43 Billion IDR | -717.394% |
| PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 4882.355% |
| PT Medikaloka Hermina Tbk | 780.69 Billion IDR | -121.377% |
| PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | -43.186% |
| PT Murni Sadar Tbk | 15.2 Billion IDR | -11265.785% |
| PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | -745.462% |
| PT Royal Prima Tbk | -4.62 Billion IDR | 37492.158% |
| PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | -5759.112% |
| PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | -3551.808% |
| PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | -1526.453% |